Peter C. Giardina

1.7k total citations
55 papers, 1.2k citations indexed

About

Peter C. Giardina is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Peter C. Giardina has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 25 papers in Microbiology and 10 papers in Immunology. Recurrent topics in Peter C. Giardina's work include Pneumonia and Respiratory Infections (44 papers), Respiratory viral infections research (24 papers) and Bacterial Infections and Vaccines (24 papers). Peter C. Giardina is often cited by papers focused on Pneumonia and Respiratory Infections (44 papers), Respiratory viral infections research (24 papers) and Bacterial Infections and Vaccines (24 papers). Peter C. Giardina collaborates with scholars based in United States, Germany and Poland. Peter C. Giardina's co-authors include Michael A. Apicella, William C. Gruber, M.A. Julie Westerink, Daniel A. Scott, Thomas Kieber‐Emmons, Beate Schmöele-Thoma, Emilio A. Emini, Kathrin U. Jansen, David W. Dyer and L A Foster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Peter C. Giardina

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter C. Giardina United States	21	747	404	203	195	159	55	1.2k
Gowrisankar Rajam United States	15	550 0.7×	246 0.6×	227 1.1×	315 1.6×	207 1.3×	30	1.0k
David E. Briles United States	15	805 1.1×	428 1.1×	121 0.6×	261 1.3×	101 0.6×	18	1.1k
Germie P. J. M. van den Dobbelsteen Netherlands	18	686 0.9×	496 1.2×	128 0.6×	180 0.9×	105 0.7×	39	999
Raymond Borrow United Kingdom	17	761 1.0×	684 1.7×	164 0.8×	305 1.6×	154 1.0×	22	1.2k
L. Pais United States	14	1.3k 1.7×	1.0k 2.5×	119 0.6×	301 1.5×	143 0.9×	15	1.7k
J Henrichsen Denmark	12	634 0.8×	333 0.8×	114 0.6×	144 0.7×	133 0.8×	18	963
Patricia Holder United States	14	755 1.0×	432 1.1×	65 0.3×	158 0.8×	93 0.6×	20	1.0k
Germie van den Dobbelsteen Netherlands	17	597 0.8×	455 1.1×	95 0.5×	101 0.5×	106 0.7×	27	816
Tine Dalby Denmark	21	1.0k 1.4×	811 2.0×	70 0.3×	92 0.5×	222 1.4×	44	1.3k
Hong‐Yin Wu United States	10	433 0.6×	286 0.7×	84 0.4×	270 1.4×	113 0.7×	12	769

Countries citing papers authored by Peter C. Giardina

Since Specialization

Citations

This map shows the geographic impact of Peter C. Giardina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Giardina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Giardina more than expected).

Fields of papers citing papers by Peter C. Giardina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Giardina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Giardina. The network helps show where Peter C. Giardina may publish in the future.

Co-authorship network of co-authors of Peter C. Giardina

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Giardina. A scholar is included among the top collaborators of Peter C. Giardina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Giardina. Peter C. Giardina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martinón‐Torres, Federico, James Trammel, Yahong Peng, et al.. (2025). A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccine. Vaccine. 53. 126931–126931.

Senders, Shelly, Allison Thompson, Mark Cutler, et al.. (2025). Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infants. Vaccine. 68. 127916–127916.

Peng, Yahong, et al.. (2024). A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants. International Journal of Infectious Diseases. 141. 106942–106942. 2 indexed citations

Senders, Shelly, Nicola P. Klein, Allison Thompson, et al.. (2024). A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. The Pediatric Infectious Disease Journal. 43(6). 596–603. 21 indexed citations

Yamazaki, Yoshitaka, Masanori Ikeda, Takayuki Imada, et al.. (2021). A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6–64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines. Vaccine. 39(43). 6414–6421. 2 indexed citations

Wysocki, Jacek, Jerzy Brzostek, Ewa Majda-Stanisławska, et al.. (2017). A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations. Vaccine. 35(15). 1926–1935. 27 indexed citations

Martinón‐Torres, Federico, Jacek Wysocki, Hanna Czajka, et al.. (2016). Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants. The Pediatric Infectious Disease Journal. 36(3). 326–332. 11 indexed citations

Zhu, Fengcai, Yuemei Hu, Jingxin Li, et al.. (2016). Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China. The Pediatric Infectious Disease Journal. 35(9). 999–1010. 8 indexed citations

Cordonnier, Catherine, Per Ljungman, Christine Juergens, et al.. (2015). Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study. Clinical Infectious Diseases. 61(3). 313–323. 69 indexed citations

10.

Martinón‐Torres, Federico, Hanna Czajka, Jacek Wysocki, et al.. (2015). 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants. PEDIATRICS. 135(4). e876–e886. 33 indexed citations

11.

Gadzinowski, Janusz, S. Tansey, Jacek Wysocki, et al.. (2014). Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age. The Pediatric Infectious Disease Journal. 34(2). 180–185. 6 indexed citations

12.

Thompson, Allison, Douglas Girgenti, Peter C. Giardina, et al.. (2013). Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.. PubMed. 33(6). 414–21. 4 indexed citations

13.

Kim, Dong Soo, Seon Hee Shin, Hoan Jong Lee, et al.. (2012). Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Given to Korean Children Receiving Routine Pediatric Vaccines. The Pediatric Infectious Disease Journal. 32(3). 266–273. 18 indexed citations

14.

Giménez‐Sánchez, Francisco, Dorothee Kieninger, Federico Martinón‐Torres, et al.. (2011). Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Vaccine. 29(35). 6042–6048. 17 indexed citations

15.

Wysocki, Jacek, et al.. (2010). Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines. Vaccine. 28(49). 7779–7786. 7 indexed citations

16.

Schwarz, Tino F., H. C. Rümke, C. Juergens, et al.. (2009). Safety and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Given Concomitantly with Trivalent Inactivated Influenza Vaccine in Healthy Adults. Journal of the American Geriatrics Society. 57.

17.

Giardina, Peter C., Theresa L. Gioannini, Anthony Zaleski, et al.. (2001). Construction of Acetate Auxotrophs of Neisseria meningitidis to Study Host-Meningococcal Endotoxin Interactions. Journal of Biological Chemistry. 276(8). 5883–5891. 53 indexed citations

18.

Giardina, Peter C., et al.. (1995). Identification of alcA, a Bordetella bronchiseptica gene necessary for alcaligin production. Gene. 167(1-2). 133–136. 32 indexed citations

19.

Westerink, M.A. Julie, Anthony A. Campagnari, Peter C. Giardina, & Michael A. Apicella. (1994). Antiidiotype Antibodies As Surrogates for Polysaccharide Vaccines. Annals of the New York Academy of Sciences. 730(1). 209–216. 1 indexed citations

20.

Westerink, M.A. Julie & Peter C. Giardina. (1992). Anti-idiotype induced protection against Neisseria meningitidis serogroup C bacteremia. Microbial Pathogenesis. 12(1). 19–26. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact